NHS lung cancer patients first in Europe to access new drug that can halt ‘Death Star’ mutation of tumour positivelysharing 3 years ago Reading Time: < 1 minute NHS lung cancer patients will be the first in Europe to receive a “ground-breaking” new medicine which can stop the growth of tumours. Read More